Our study suggests that increased AcH3 and AcH4 levels play critical roles in high calcium/high phosphate–induced AV calcification and that reduction of histone 3/4 acetylation via HAT inhibition may be a novel strategy for controlling calcium metabolic disorders associated with AV calcification in patients with chronic renal insufficiency. Here, TMPRSS11D is linked to metabolic disease.